These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 22876789)

  • 1. Recovering independent associations in genetics: a comparison.
    Sperrin M; Jaki T
    J Comput Biol; 2012 Aug; 19(8):978-87. PubMed ID: 22876789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation strategies for reacting to the identification of an association between the genome and adverse drug reactions.
    Thygesen H; Su TL; Whitehead J; Bowman C
    J Biopharm Stat; 2011 Jan; 21(1):111-24. PubMed ID: 21191858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline resistance and virological outcome in patients with virological failure who start a regimen containing abacavir: EuroSIDA study.
    Cabrera C; Cozzi-Lepri A; Phillips AN; Loveday C; Kirk O; Ait-Khaled M; Reiss P; Kjaer J; Ledergerber B; Lundgren JD; Clotet B; Ruiz L;
    Antivir Ther; 2004 Oct; 9(5):787-800. PubMed ID: 15535417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of model-based tests and selection strategies to detect genetic polymorphisms influencing pharmacokinetic parameters.
    Bertrand J; Comets E; Mentre F
    J Biopharm Stat; 2008; 18(6):1084-102. PubMed ID: 18991109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fine mapping of disease genes using tagging SNPs.
    Sjölander A; Hössjer O; Hartman LW; Humphreys K
    Ann Hum Genet; 2007 Nov; 71(Pt 6):815-27. PubMed ID: 17587339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Monitoring anti-retroviral treatment].
    Miró JM; Pumarola T; Soriano V; Bouza E
    Enferm Infecc Microbiol Clin; 1996 Oct; 14 Suppl 1():44-50. PubMed ID: 9053027
    [No Abstract]   [Full Text] [Related]  

  • 7. A two-stage mixed-effects model approach for gene-set analyses in candidate gene studies.
    Tsonaka R; van der Helm-van Mil AH; Houwing-Duistermaat JJ
    Stat Med; 2012 May; 31(11-12):1190-202. PubMed ID: 21997511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of tenofovir versus abacavir on HIV-related endothelial dysfunction.
    Francisci D; Falcinelli E; Belfiori B; Petito E; Fierro T; Baldelli F; Gresele P
    AIDS Patient Care STDS; 2011 Oct; 25(10):567-9. PubMed ID: 21851265
    [No Abstract]   [Full Text] [Related]  

  • 9. Abacavir and increased risk of myocardial infarction.
    Goicoechea M; McCutchan A
    Lancet; 2008 Sep; 372(9641):803-4; author reply 804-5. PubMed ID: 18774413
    [No Abstract]   [Full Text] [Related]  

  • 10. Will pharmacogenomic discoveries improve HIV therapeutics?
    Haas DW
    Top HIV Med; 2005; 13(3):90-5. PubMed ID: 16170225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical implications of antiretroviral pharmacogenomics.
    Fox J; Boffito M; Winston A
    Pharmacogenomics; 2006 Jun; 7(4):587-96. PubMed ID: 16753006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individualising HIV treatment--pharmacogenetics and immunogenetics.
    Telenti A; Aubert V; Spertini F
    Lancet; 2002 Mar; 359(9308):722-3. PubMed ID: 11888578
    [No Abstract]   [Full Text] [Related]  

  • 13. Accounting for haplotype uncertainty in matched association studies: a comparison of simple and flexible techniques.
    Kraft P; Cox DG; Paynter RA; Hunter D; De Vivo I
    Genet Epidemiol; 2005 Apr; 28(3):261-72. PubMed ID: 15637718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using iterative ridge regression to explore associations between conditioned variables.
    Bar-Yaakov N; Grossman Z; Intrator N
    J Comput Biol; 2012 May; 19(5):504-18. PubMed ID: 22468679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel Bayesian semiparametric algorithm for inferring population structure and adjusting for case-control association tests.
    Majumdar A; Bhattacharya S; Basu A; Ghosh S
    Biometrics; 2013 Mar; 69(1):164-73. PubMed ID: 23432096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of genome-wide significant single-nucleotide polymorphisms and antiretroviral therapy to dyslipidemia in HIV-infected individuals: a longitudinal study.
    Rotger M; Bayard C; Taffé P; Martinez R; Cavassini M; Bernasconi E; Battegay M; Hirschel B; Furrer H; Witteck A; Weber R; Ledergerber B; Telenti A; Tarr PE;
    Circ Cardiovasc Genet; 2009 Dec; 2(6):621-8. PubMed ID: 20031643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Bayesian clustering approach for detecting gene-gene interactions in high-dimensional genotype data.
    Chen SP; Huang GH
    Stat Appl Genet Mol Biol; 2014 Jun; 13(3):275-97. PubMed ID: 24846958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Latent variable modeling paradigms for genotype-trait association studies.
    Liu Y; Foulkes AS
    Biom J; 2011 Sep; 53(5):838-54. PubMed ID: 21887796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New nucleoside reverse transcriptase inhibitors for the treatment of HIV infections.
    Otto MJ
    Curr Opin Pharmacol; 2004 Oct; 4(5):431-6. PubMed ID: 15351346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The fuss over 1592.
    Vazquez E
    Posit Aware; 1997; 8(5):26-7. PubMed ID: 11364637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.